Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Inj. insulin degludec with insulin aspart

Inj. insulin degludec 100 iu/ml, 3ml cartridge

Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Insulin degludec (r-dna origin)100iu/ml in 3ml penfills

Amino acid, lipids, glucose, electrolytes, triglycerides, nitrogen 5.4g, carbohydrates 100g, energy content total 3780kj, ph 5.6, 1026ml,chromium chloride 4mcg, copper sulphate 0.40mg, manganese sulphate 0.1mg, selenium 20mcg, zinc sulfate 1mg,eicosapentaenoic acid 1.25gm , docosahexanoic acid 1.44gm,tocopherol 0.015 -0.0296 gm,glycerol 2.5 gm,purified egg phosphotide 1.2 gm,sodium celate ,sodium hydroxide ,water for injection 50ml,fish oil 0.1 g, egg phospholipids 0.012 g, glycerin 0.025 g, dl alpha tocopherol 0.15 to 0.3 mg, sodium oleate 0.3 mg, , water for injection, 50 ml,human coagulation factor ii 280-760,human coagulation factor vii 180-480,human ix 500iu,factor x 360-600iu,protein c 260-620iu,protein s 240-640iu , total protein 260-820mg, human prothrombin complex,humi insulin 40iu - monocomponent biosynthetic r-dna insulin 40iu,humi insulin biphasic 40iu soluble insulin , isophane insulin metacresol u.s.p 1.5mg pheno ip - 0.65mg,influenza vaccine adult,insulin glargine 100iu,insulin isophane , human

For complete deion and other details, please refer to tender

For complete deion and other details, please refer to tender